The implanted thymic tissue provides the human environment required for developing human T cells to mature and undergo education. At the same time, human hematopoietic stem cells generate immune cells within the mouse. This coordination links human immune-cell production with human T-cell development, helping the model reproduce immune responses relevant to human infection and immunology.
After engraftment, human hematopoietic stem cells serve as the source of the model’s human immune-cell population. Their development occurs alongside the implanted human thymic tissue, which supports T-cell maturation and education. This cellular reconstitution gives investigators an in vivo system for examining how human immune cells respond during infection or after an immunological intervention.
Conventional mouse models may not accurately reproduce human biology in studies requiring human-specific immune responses or host-pathogen interactions. The BLT model addresses this limitation by combining human hematopoietic stem cells with human thymic tissue, allowing researchers to examine these processes in vivo. Its value is greatest when species-specific immune behavior affects interpretation of the experiment.
Establishment begins with an immunodeficient mouse, followed by reconstitution with human bone marrow, liver, and thymus tissues. Human hematopoietic stem cells then engraft and generate immune cells, while the human thymic implant supports T-cell maturation and education. Once this human immune system has developed, the model can be used for in vivo infection or intervention studies.
Humanized BLT mice provide an in vivo setting for studying HIV within a human immune context. Researchers can examine host-pathogen interactions and human-specific immune responses during infection, then use the same platform to evaluate antiviral therapies. This combination connects infection biology with treatment testing in a model that conventional mice may not accurately represent.
The system can support evaluation of vaccines, antiviral therapies, and other immunological interventions. Because the model develops human immune cells and human T-cell maturation is supported by thymic tissue, investigators can assess interventions in relation to human-specific immune responses. The resulting in vivo data are especially useful when conventional mouse biology does not adequately reproduce the human response of interest.